Influenza
Conditions
Interventions
Test group: Jiawei Qingfei Decoction combined with Oseltamivir Phosphate Capsules for oral use
Control group:Oseltamivir phosphate capsule for oral use
Sponsors
Dongzhimen Hospital, Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Meeting the diagnostic criteria for influenza in Western medicine and the syndrome differentiation criteria of heat-toxin attacking the lung in Traditional Chinese Medicine; (2) Enrolled with an axillary temperature of = 37.8? and a disease course of 48 hours or less; (3) Age ranging from 18 to 65 years old (inclusive) with no gender restrictions; (4) Voluntary participants who have signed the informed consent form for this study.
Exclusion criteria
Exclusion criteria: (1) severe patients with influenza such as persistent high fever axillary temperature = 39.1 ? dyspnea somnolence convulsion severe vomiting or diarrhea dehydration and pneumonia; critically ill patients such as respiratory failure acute necrotizing encephalopathy shock multiple organ dysfunction; (2) patients with complications (3) those whose white cell count is more than 12 × 10^9 and the percentage of neutrophils is higher than the normal upper limit.(4) before joining the groupPatients with this disease were treated with related drugs within 12 hours such as antiviral antipyretic and analgesic drugs and drugs similar to the efficacy of the experimental drugs; (5) those with allergic constitution or allergic to the components of the experimental drugs such as the careful use and prohibition of ephedra including insomnia hypertension and arrhythmia; (6) patients with severe primary diseases such as heart brain liver and kidney. (7) there is immunodeficiency or immunosuppression such as AIDS malignant tumor organ transplantation or taking immunosuppressants within 3 months; (8) pregnant or lactating women; (9) those who suspect or do have a history of alcohol or drug abuse; (10) those who are considered inappropriate to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to Complete Defervescence;Fever Resolution Rates at Specific Time Points; | — |
Secondary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine Symptom Score;Efficacy of Traditional Chinese Medicine Syndromes;Dosage of Antipyretic Drugs;Laboratory Test Indicators; | — |
Countries
China
Contacts
Public ContactLi Yan
Dongzhimen Hospital, Beijing University of Chinese Medicine
Outcome results
None listed